Michael Ulz's Stock Ratings

Morgan Stanley Analyst

Michael Ulz is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/21/2025

Overall Average Return

7.85%

Smart Score

58.5%

Overall Average Return Percentile

57th

Number of Ratings

160
Buy NowGet Alert
03/10/2025AARDBuy Now
Aardvark Therapeutics
$10.20184.31%
Michael Ulz58%
→ $29Initiates → OverweightGet Alert
03/05/2025YMABBuy Now
Y-mAbs Therapeutics
$4.9242.28%
Michael Ulz58%
$11 → $7MaintainsUnderweightGet Alert
03/05/2025SLNBuy Now
Silence Therapeutics
$3.701116.22%
Michael Ulz58%
$49 → $45MaintainsOverweightGet Alert
03/03/2025KPTIBuy Now
Karyopharm Therapeutics
$5.96806.39%
Michael Ulz58%
$75 → $54MaintainsOutperformGet Alert
02/28/2025IOVABuy Now
Iovance Biotherapeutics
$3.56461.8%
Michael Ulz58%
$24 → $20MaintainsOutperformGet Alert
02/14/2025ALNYBuy Now
Alnylam Pharmaceuticals
$253.5412.01%
Michael Ulz58%
$275 → $284MaintainsEqual-WeightGet Alert
02/12/2025THRDBuy Now
Third Harmonic Bio
$3.5540.85%
Michael Ulz58%
$20 → $5DowngradeOverweight → Equal-WeightGet Alert
02/03/2025GUTSBuy Now
Fractyl Health
$1.24706.39%
Michael Ulz58%
$18 → $10MaintainsOverweightGet Alert
01/28/2025AKROBuy Now
Akero Therapeutics
$44.66114.96%
Michael Ulz58%
$46 → $96MaintainsOverweightGet Alert
10/08/2024SLNBuy Now
Silence Therapeutics
$3.701224.32%
Michael Ulz58%
$49 → $49ReiteratesOverweight → OverweightGet Alert
09/12/2024VKTXBuy Now
Viking Therapeutics
$28.41269.59%
Michael Ulz58%
$105 → $105ReiteratesOverweight → OverweightGet Alert
08/14/2024DYNBuy Now
Dyne Therapeutics
$12.26324.14%
Michael Ulz58%
$48 → $52MaintainsOverweightGet Alert
08/13/2024YMABBuy Now
Y-mAbs Therapeutics
$4.92123.58%
Michael Ulz58%
$12 → $11MaintainsUnderweightGet Alert
08/09/2024THRDBuy Now
Third Harmonic Bio
$3.55463.38%
Michael Ulz58%
$12 → $20UpgradeEqual-Weight → OverweightGet Alert
07/12/2024BPMCBuy Now
Blueprint Medicines
$88.4729.99%
Michael Ulz58%
$110 → $115MaintainsEqual-WeightGet Alert
07/12/2024ALNYBuy Now
Alnylam Pharmaceuticals
$253.540.57%
Michael Ulz58%
$250 → $255MaintainsEqual-WeightGet Alert
06/28/2024SLNBuy Now
Silence Therapeutics
$3.701224.32%
Michael Ulz58%
$45 → $49MaintainsOverweightGet Alert
06/27/2024VKTXBuy Now
Viking Therapeutics
$28.41269.59%
Michael Ulz58%
→ $105Initiates → OverweightGet Alert
06/25/2024ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-1.4%
Michael Ulz58%
$164 → $250MaintainsEqual-WeightGet Alert
06/18/2024MIRMBuy Now
Mirum Pharmaceuticals
$49.0016.33%
Michael Ulz58%
$53 → $57MaintainsOverweightGet Alert
05/13/2024ARWRBuy Now
Arrowhead Pharma
$15.0080%
Michael Ulz58%
$36 → $27MaintainsEqual-WeightGet Alert
05/10/2024MIRMBuy Now
Mirum Pharmaceuticals
$49.008.16%
Michael Ulz58%
$57 → $53MaintainsOverweightGet Alert
04/30/2024DYNBuy Now
Dyne Therapeutics
$12.26226.26%
Michael Ulz58%
→ $40Initiates → OverweightGet Alert
04/22/2024SLNBuy Now
Silence Therapeutics
$3.701116.22%
Michael Ulz58%
$45 → $45MaintainsOverweightGet Alert
04/11/2024ALPNBuy Now
Alpine Immune Sciences
Michael Ulz58%
$47 → $65DowngradeOverweight → Equal-WeightGet Alert
03/19/2024ALPNBuy Now
Alpine Immune Sciences
Michael Ulz58%
$30 → $47MaintainsOverweightGet Alert
03/14/2024SLNBuy Now
Silence Therapeutics
$3.701116.22%
Michael Ulz58%
$29 → $45MaintainsOverweightGet Alert
03/04/2024KYTXBuy Now
Kyverna Therapeutics
$2.281654.39%
Michael Ulz58%
→ $40Initiates → OverweightGet Alert
02/27/2024FATEBuy Now
Fate Therapeutics
$0.92660.79%
Michael Ulz58%
$3 → $7MaintainsEqual-WeightGet Alert
02/27/2024GUTSBuy Now
Fractyl Health
$1.241351.5%
Michael Ulz58%
→ $18Initiates → OverweightGet Alert
02/13/2024ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-30.58%
Michael Ulz58%
$184 → $176MaintainsEqual-WeightGet Alert
02/07/2024ARWRBuy Now
Arrowhead Pharma
$15.00140%
Michael Ulz58%
$34 → $36MaintainsEqual-WeightGet Alert
01/05/2024ALVRBuy Now
AlloVir
$9.67-94.83%
Michael Ulz58%
$23 → $11.5DowngradeEqual-Weight → UnderweightGet Alert
12/22/2023ALVRBuy Now
AlloVir
$9.67-89.66%
Michael Ulz58%
$460 → $23DowngradeOverweight → Equal-WeightGet Alert
11/30/2023ARWRBuy Now
Arrowhead Pharma
$15.00146.67%
Michael Ulz58%
$40 → $37MaintainsEqual-WeightGet Alert
11/29/2023CABABuy Now
Cabaletta Bio
$1.801289.27%
Michael Ulz58%
$28 → $25MaintainsOverweightGet Alert
11/13/2023FATEBuy Now
Fate Therapeutics
$0.92226.05%
Michael Ulz58%
$5 → $3MaintainsEqual-WeightGet Alert
11/13/2023MIRMBuy Now
Mirum Pharmaceuticals
$49.0022.45%
Michael Ulz58%
→ $60Initiates → OverweightGet Alert
11/08/2023CABABuy Now
Cabaletta Bio
$1.801455.99%
Michael Ulz58%
$16 → $28MaintainsOverweightGet Alert
11/03/2023IONSBuy Now
Ionis Pharmaceuticals
$32.6347.1%
Michael Ulz58%
$45 → $48MaintainsEqual-WeightGet Alert
11/03/2023ALPNBuy Now
Alpine Immune Sciences
Michael Ulz58%
$17 → $30MaintainsOverweightGet Alert
11/03/2023ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-27.82%
Michael Ulz58%
$175 → $183MaintainsEqual-WeightGet Alert
10/27/2023BPMCBuy Now
Blueprint Medicines
$88.47-28.79%
Michael Ulz58%
$59 → $63MaintainsEqual-WeightGet Alert
10/11/2023AKROBuy Now
Akero Therapeutics
$44.66-26.11%
Michael Ulz58%
$70 → $33MaintainsOverweightGet Alert
10/10/2023ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-30.98%
Michael Ulz58%
$210 → $175MaintainsEqual-WeightGet Alert
09/27/2023IONSBuy Now
Ionis Pharmaceuticals
$32.6337.91%
Michael Ulz58%
$42 → $45MaintainsEqual-WeightGet Alert
08/16/2023ORICBuy Now
ORIC Pharmaceuticals
$7.51259.52%
Michael Ulz58%
$15 → $27MaintainsOutperformGet Alert
08/14/2023YMABBuy Now
Y-mAbs Therapeutics
$4.921.63%
Michael Ulz58%
$7 → $5MaintainsUnderweightGet Alert
08/11/2023THRDBuy Now
Third Harmonic Bio
$3.5597.18%
Michael Ulz58%
$5 → $7MaintainsEqual-WeightGet Alert
08/10/2023FATEBuy Now
Fate Therapeutics
$0.92443.42%
Michael Ulz58%
$8 → $5MaintainsEqual-WeightGet Alert
08/09/2023MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$42 → $37MaintainsEqual-WeightGet Alert
08/07/2023KPTIBuy Now
Karyopharm Therapeutics
$5.96-32.86%
Michael Ulz58%
$75 → $60MaintainsEqual-WeightGet Alert
08/07/2023ALVRBuy Now
AlloVir
$9.67106.83%
Michael Ulz58%
$460 → $460ReiteratesOverweight → OverweightGet Alert
08/04/2023ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-17.17%
Michael Ulz58%
$210 → $210ReiteratesEqual-Weight → Equal-WeightGet Alert
08/03/2023BPMCBuy Now
Blueprint Medicines
$88.47-33.31%
Michael Ulz58%
$55 → $59MaintainsEqual-WeightGet Alert
07/24/2023SLNBuy Now
Silence Therapeutics
$3.70440.54%
Michael Ulz58%
$20 → $20ReiteratesOverweight → OverweightGet Alert
07/17/2023SLNBuy Now
Silence Therapeutics
$3.70440.54%
Michael Ulz58%
$20 → $20ReiteratesOverweight → OverweightGet Alert
07/14/2023MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$51 → $42MaintainsEqual-WeightGet Alert
07/14/2023BPMCBuy Now
Blueprint Medicines
$88.47-37.83%
Michael Ulz58%
$55 → $55ReiteratesEqual-Weight → Equal-WeightGet Alert
06/26/2023SLNBuy Now
Silence Therapeutics
$3.70440.54%
Michael Ulz58%
$20 → $20ReiteratesOverweight → OverweightGet Alert
06/20/2023SLNBuy Now
Silence Therapeutics
$3.70440.54%
Michael Ulz58%
→ $20Reiterates → OverweightGet Alert
06/12/2023SLNBuy Now
Silence Therapeutics
$3.70440.54%
Michael Ulz58%
→ $20Reiterates → OverweightGet Alert
06/12/2023AKROBuy Now
Akero Therapeutics
$44.6656.74%
Michael Ulz58%
$65 → $70MaintainsOverweightGet Alert
05/23/2023IOVABuy Now
Iovance Biotherapeutics
$3.56546.07%
Michael Ulz58%
$20 → $23MaintainsOutperformGet Alert
05/10/2023YMABBuy Now
Y-mAbs Therapeutics
$4.9242.28%
Michael Ulz58%
$4 → $7MaintainsUnderweightGet Alert
05/10/2023IOVABuy Now
Iovance Biotherapeutics
$3.56461.8%
Michael Ulz58%
$25 → $20MaintainsOutperformGet Alert
05/08/2023SLNBuy Now
Silence Therapeutics
$3.70440.54%
Michael Ulz58%
→ $20Initiates → OverweightGet Alert
05/05/2023BPMCBuy Now
Blueprint Medicines
$88.47-37.83%
Michael Ulz58%
$50 → $55MaintainsEqual-WeightGet Alert
05/03/2023ARWRBuy Now
Arrowhead Pharma
$15.00166.67%
Michael Ulz58%
$37 → $40MaintainsEqual-WeightGet Alert
05/01/2023ISEEBuy Now
IVERIC bio
Michael Ulz58%
$35 → $40DowngradeOverweight → Equal-WeightGet Alert
04/25/2023ISEEBuy Now
IVERIC bio
Michael Ulz58%
$30 → $35MaintainsOverweightGet Alert
04/11/2023IONSBuy Now
Ionis Pharmaceuticals
$32.6328.72%
Michael Ulz58%
$40 → $42MaintainsEqual-WeightGet Alert
04/04/2023ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-17.17%
Michael Ulz58%
$205 → $210MaintainsEqual-WeightGet Alert
03/24/2023SNTIBuy Now
Senti Biosciences
$3.79-47.23%
Michael Ulz58%
$30 → $20MaintainsEqual-WeightGet Alert
02/24/2023ALNYBuy Now
Alnylam Pharmaceuticals
$253.54-19.15%
Michael Ulz58%
$210 → $205MaintainsEqual-WeightGet Alert
02/01/2023RCKTBuy Now
Rocket Pharmaceuticals
$8.44433.23%
Michael Ulz58%
→ $45Initiates → OverweightGet Alert
01/27/2023XLOBuy Now
Xilio Therapeutics
$0.771207.19%
Michael Ulz58%
$20 → $10MaintainsOverweightGet Alert
01/27/2023SNTIBuy Now
Senti Biosciences
$3.79-20.84%
Michael Ulz58%
$75 → $30MaintainsEqual-WeightGet Alert
01/27/2023MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$60 → $50MaintainsEqual-WeightGet Alert
01/27/2023KPTIBuy Now
Karyopharm Therapeutics
$5.96-16.07%
Michael Ulz58%
$105 → $75MaintainsEqual-WeightGet Alert
01/27/2023BPMCBuy Now
Blueprint Medicines
$88.47-43.48%
Michael Ulz58%
$75 → $50MaintainsEqual-WeightGet Alert
01/27/2023ALVRBuy Now
AlloVir
$9.67106.83%
Michael Ulz58%
$621 → $460MaintainsOverweightGet Alert
01/27/2023ALLKBuy Now
Allakos
$0.262952.27%
Michael Ulz58%
$6 → $8MaintainsEqual-WeightGet Alert
01/27/2023YMABBuy Now
Y-mAbs Therapeutics
$4.92
Michael Ulz58%
DowngradeEqual-Weight → UnderweightGet Alert
01/27/2023CABABuy Now
Cabaletta Bio
$1.80789.14%
Michael Ulz58%
→ $16UpgradeEqual-Weight → OverweightGet Alert
01/27/2023TSHABuy Now
Taysha Gene Therapies
$1.6878.57%
Michael Ulz58%
→ $3DowngradeOverweight → Equal-WeightGet Alert
01/27/2023AKROBuy Now
Akero Therapeutics
$44.6645.54%
Michael Ulz58%
→ $65UpgradeEqual-Weight → OverweightGet Alert
01/27/2023VIRBuy Now
Vir Biotechnology
$6.87336.68%
Michael Ulz58%
$18 → $30UpgradeUnderweight → Equal-WeightGet Alert
01/19/2023ALPNBuy Now
Alpine Immune Sciences
Michael Ulz58%
→ $17Initiates → OverweightGet Alert
01/06/2023FATEBuy Now
Fate Therapeutics
$0.92769.47%
Michael Ulz58%
$35 → $8MaintainsEqual-WeightGet Alert
12/21/2022IONSBuy Now
Ionis Pharmaceuticals
$32.6322.59%
Michael Ulz58%
$56 → $40DowngradeOverweight → Equal-WeightGet Alert
12/16/2022THRDBuy Now
Third Harmonic Bio
$3.5540.85%
Michael Ulz58%
$34 → $5DowngradeOverweight → Equal-WeightGet Alert
12/14/2022MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$70 → $60MaintainsEqual-WeightGet Alert
11/02/2022BPMCBuy Now
Blueprint Medicines
$88.47-15.23%
Michael Ulz58%
$80 → $75MaintainsEqual-WeightGet Alert
10/31/2022YMABBuy Now
Y-mAbs Therapeutics
$4.9262.6%
Michael Ulz58%
$17 → $8MaintainsEqual-WeightGet Alert
10/10/2022THRDBuy Now
Third Harmonic Bio
$3.55857.75%
Michael Ulz58%
→ $34Initiates → OverweightGet Alert
10/07/2022SNTIBuy Now
Senti Biosciences
$3.7997.89%
Michael Ulz58%
→ $75Initiates → Equal-WeightGet Alert
09/09/2022YMABBuy Now
Y-mAbs Therapeutics
$4.92245.53%
Michael Ulz58%
$15 → $17MaintainsEqual-WeightGet Alert
09/09/2022KPTIBuy Now
Karyopharm Therapeutics
$5.9617.5%
Michael Ulz58%
$150 → $105MaintainsEqual-WeightGet Alert
09/09/2022FATEBuy Now
Fate Therapeutics
$0.923703.93%
Michael Ulz58%
$45 → $35MaintainsEqual-WeightGet Alert
09/09/2022BPMCBuy Now
Blueprint Medicines
$88.47-9.57%
Michael Ulz58%
$65 → $80MaintainsEqual-WeightGet Alert
08/30/2022CABABuy Now
Cabaletta Bio
$1.8066.71%
Michael Ulz58%
$15 → $3DowngradeOverweight → Equal-WeightGet Alert
08/10/2022XLOBuy Now
Xilio Therapeutics
$0.772514.38%
Michael Ulz58%
$32 → $20MaintainsOverweightGet Alert
08/05/2022IOVABuy Now
Iovance Biotherapeutics
$3.56602.25%
Michael Ulz58%
$34 → $25MaintainsOutperformGet Alert
08/04/2022HZNPBuy Now
Horizon Therapeutics
Michael Ulz58%
$135 → $90MaintainsOverweightGet Alert
07/07/2022ISEEBuy Now
IVERIC bio
Michael Ulz58%
$25 → $30MaintainsOverweightGet Alert
06/14/2022BPMCBuy Now
Blueprint Medicines
$88.47-26.53%
Michael Ulz58%
$92 → $65MaintainsEqual-WeightGet Alert
05/11/2022JNCEBuy Now
Jounce Therapeutics
Michael Ulz58%
$15 → $7DowngradeOutperform → NeutralGet Alert
05/10/2022ALLKBuy Now
Allakos
$0.262189.2%
Michael Ulz58%
$8 → $6MaintainsEqual-WeightGet Alert
05/05/2022MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$140 → $100MaintainsEqual-WeightGet Alert
05/05/2022HZNPBuy Now
Horizon Therapeutics
Michael Ulz58%
$140 → $135MaintainsOverweightGet Alert
05/05/2022FATEBuy Now
Fate Therapeutics
$0.924790.77%
Michael Ulz58%
$52 → $45MaintainsEqual-WeightGet Alert
03/30/2022IGMSBuy Now
IGM Biosciences
$1.202400%
Michael Ulz58%
$25 → $30MaintainsEqual-WeightGet Alert
03/01/2022MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$150 → $140MaintainsEqual-WeightGet Alert
02/07/2022ISEEBuy Now
IVERIC bio
Michael Ulz58%
→ $25Initiates → OverweightGet Alert
02/01/2022MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$175 → $150MaintainsEqual-WeightGet Alert
02/01/2022FRLNBuy Now
Freeline Therapeutics
Michael Ulz58%
DowngradeOverweight → Equal-WeightGet Alert
01/05/2022AVROBuy Now
Avrobio
Michael Ulz58%
$84 → $36MaintainsEqual-WeightGet Alert
12/23/2021ALLKBuy Now
Allakos
$0.263715.34%
Michael Ulz58%
$86 → $10MaintainsEqual-WeightGet Alert
12/15/2021CABABuy Now
Cabaletta Bio
$1.80733.56%
Michael Ulz58%
$20 → $15MaintainsOverweightGet Alert
12/15/2021FATEBuy Now
Fate Therapeutics
$0.926638.4%
Michael Ulz58%
$74 → $62MaintainsEqual-WeightGet Alert
12/14/2021IGMSBuy Now
IGM Biosciences
$1.203066.67%
Michael Ulz58%
$100 → $38DowngradeOverweight → Equal-WeightGet Alert
11/19/2021AVROBuy Now
Avrobio
Michael Ulz58%
$288 → $84DowngradeOverweight → Equal-WeightGet Alert
11/19/2021KPTIBuy Now
Karyopharm Therapeutics
$5.9667.85%
Michael Ulz58%
$405 → $150DowngradeOverweight → Equal-WeightGet Alert
11/16/2021XLOBuy Now
Xilio Therapeutics
$0.774083.01%
Michael Ulz58%
→ $32Initiates → OverweightGet Alert
11/10/2021ALLKBuy Now
Allakos
$0.2632711.9%
Michael Ulz58%
$88 → $86MaintainsEqual-WeightGet Alert
09/21/2021MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
$160 → $173MaintainsEqual-WeightGet Alert
08/26/2021HZNPBuy Now
Horizon Therapeutics
Michael Ulz58%
$103 → $135MaintainsOverweightGet Alert
08/26/2021IGMSBuy Now
IGM Biosciences
$1.208233.33%
Michael Ulz58%
→ $100Initiates → OverweightGet Alert
08/26/2021FATEBuy Now
Fate Therapeutics
$0.928268.66%
Michael Ulz58%
→ $77Initiates → Equal-WeightGet Alert
08/26/2021MRTXBuy Now
Mirati Therapeutics
Michael Ulz58%
→ $160Initiates → Equal-WeightGet Alert
08/26/2021ALLKBuy Now
Allakos
$0.2633474.97%
Michael Ulz58%
→ $88Initiates → Equal-WeightGet Alert
10/08/2020ITOSBuy Now
ITeos Therapeutics
$6.88553.59%
Michael Ulz58%
→ $45Initiates → OutperformGet Alert
09/23/2020NLTXBuy Now
Neoleukin Therapeutics
Michael Ulz58%
→ $500Initiates → OutperformGet Alert
08/13/2020ORICBuy Now
ORIC Pharmaceuticals
$7.51499.2%
Michael Ulz58%
→ $45Initiates → OutperformGet Alert
05/28/2020MRSNBuy Now
Mersana Therapeutics
$0.434551.16%
Michael Ulz58%
$12 → $20MaintainsOutperformGet Alert
04/16/2020BCELBuy Now
Atreca
Michael Ulz58%
→ $30Initiates → OutperformGet Alert
03/29/2019PRTOBuy Now
Proteon Therapeutics
Michael Ulz58%
$3 → $1MaintainsNeutralGet Alert
10/22/2018MACKBuy Now
Merrimack Pharmaceuticals
Michael Ulz58%
$7 → $4MaintainsNeutralGet Alert
09/21/2018GTXIBuy Now
Michael Ulz58%
DowngradeOutperform → NeutralGet Alert
06/26/2018MACKBuy Now
Merrimack Pharmaceuticals
Michael Ulz58%
$12 → $7MaintainsNeutralGet Alert
06/13/2018IDRABuy Now
Idera Pharmaceuticals
Michael Ulz58%
$680 → $544MaintainsOutperformGet Alert
06/04/2018JNCEBuy Now
Jounce Therapeutics
Michael Ulz58%
$35 → $20MaintainsOutperformGet Alert
05/08/2018MRSNBuy Now
Mersana Therapeutics
$0.436876.74%
Michael Ulz58%
→ $30Initiates → OutperformGet Alert
03/15/2018PRTOBuy Now
Proteon Therapeutics
Michael Ulz58%
$2 → $3MaintainsOutperformGet Alert
11/21/2017GTXIBuy Now
Michael Ulz58%
→ $17Initiates → OutperformGet Alert
11/03/2017RAREBuy Now
Ultragenyx Pharmaceutical
$38.89105.71%
Michael Ulz58%
$85 → $80MaintainsOutperformGet Alert
07/12/2017FOLDBuy Now
Amicus Therapeutics
$9.1563.93%
Michael Ulz58%
$12 → $15MaintainsOutperformGet Alert
04/24/2017IDRABuy Now
Idera Pharmaceuticals
Michael Ulz58%
→ $680Initiates → OutperformGet Alert
02/27/2017TSROBuy Now
Tesaro
Michael Ulz58%
$127 → $182DowngradeOutperform → NeutralGet Alert
02/21/2017JNCEBuy Now
Jounce Therapeutics
Michael Ulz58%
→ $30Initiates → OutperformGet Alert
01/24/2017FOLDBuy Now
Amicus Therapeutics
$9.159.29%
Michael Ulz58%
$7 → $10UpgradeNeutral → OutperformGet Alert
07/19/2016TSROBuy Now
Tesaro
Michael Ulz58%
Initiates → OutperformGet Alert
05/26/2016MACKBuy Now
Merrimack Pharmaceuticals
Michael Ulz58%
Initiates → NeutralGet Alert
04/14/2016FOLDBuy Now
Amicus Therapeutics
$9.15
Michael Ulz58%
Initiates → NeutralGet Alert
04/14/2016PRTOBuy Now
Proteon Therapeutics
Michael Ulz58%
→ $20Initiates → OutperformGet Alert
04/13/2016PRTOBuy Now
Proteon Therapeutics
Michael Ulz58%
→ $20Initiates → OutperformGet Alert
03/07/2016RAREBuy Now
Ultragenyx Pharmaceutical
$38.89118.57%
Michael Ulz58%
→ $85Initiates → OutperformGet Alert
11/17/2014PRTOBuy Now
Proteon Therapeutics
Michael Ulz58%
→ $15Initiates → OutperformGet Alert
07/15/2014RAREBuy Now
Ultragenyx Pharmaceutical
$38.8964.57%
Michael Ulz58%
→ $64Initiates → OutperformGet Alert